Surgery Partners Inc (SGRY) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Margin Pressures [Yahoo! Finance]
Surgery Partners, Inc. (SGRY)
Last surgery partners, inc. earnings: 3/5 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.surgerypartners.com/investor-overview
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Full Year Net Revenue: $3.3 billion, up 6.2% year over year. Same Facility Revenue Growth: 4.9% for the full year. Full Year Adjusted EBITDA: $526 million, up 3.5% year over year. Adjusted EBITDA Margin: 15.9%, reflecting 40 basis points of margin compression. Fourth Quarter Revenue: $885 million, up 2.4% year over year. Fourth Quarter Adjusted EBITDA: $156.9 million, with a margin of 17.7%. Fourth Quarter Same Facility Revenue Growth: Fourth Quarter Same Facility Case Growth: Full Year Surgical Cases: Nearly 670,000, up 2% from 2024. Orthopedic Cases: Over 42,000 in Q4, with total joint cases growing 15% in Q4 and 19% year-to-date. Capital Deployment for Acquisitions: $182 million in 2025. Cash and Revolver Capacity: $933 million of available liquidity at quarter end. Operating Cash Flows: $274 million in 2025. Outstanding Corporate Debt: $2.6 billion with no maturity until 2030. 2026 Revenue Guidance: $3.35 bill
Show less
Read more
Impact Snapshot
Event Time:
SGRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SGRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SGRY alerts
High impacting Surgery Partners, Inc. news events
Weekly update
A roundup of the hottest topics
SGRY
News
- Surgery Partners (SGRY) had its price target lowered by TD Cowen from $28.00 to $20.00. They now have a "buy" rating on the stock.MarketBeat
- Surgery Partners (SGRY) had its price target lowered by UBS Group AG from $29.00 to $21.00. They now have a "buy" rating on the stock.MarketBeat
- Surgery Partners (SGRY) had its price target lowered by Mizuho from $19.00 to $17.00. They now have an "outperform" rating on the stock.MarketBeat
- Has Surgery Partners (SGRY) Slump Opened A New Opportunity For Investors? [Yahoo! Finance]Yahoo! Finance
- ZIEGLER ADVISES PREFERRED VASCULAR GROUP ON ITS ACQUISITION BY SURGERY PARTNERS [Yahoo! Finance]Yahoo! Finance
SGRY
Earnings
- 3/2/26 - Miss
SGRY
Sec Filings
- 3/5/26 - Form 144
- 3/2/26 - Form 10-K
- 3/2/26 - Form 8-K
- SGRY's page on the SEC website